Powerlifting Athlete Suspended for Presence of SARM S-22

(Ottawa, Ontario – December 18, 2018) – The Canadian Centre for Ethics in Sport (CCES) announced today that Alexandra Stodalka, a powerlifting athlete, received a four-year sanction for an anti-doping rule violation. The athlete’s urine sample, collected during out-of-competition doping control on April 21, 2018, revealed the presence of SARM S-22, a prohibited anabolic agent.

In response to the CCES’s notification of the adverse analytical finding, Ms. Stodalka waived her right to a hearing and accepted the proposed sanction, which terminates on July 11, 2022. The athlete, who resides in Calgary, Alberta, is ineligible to participate in any capacity with any sport signatory to the Canadian Anti-Doping Program (CADP), including training with teammates, during the sanction period.

In compliance with rule 7.10 of the CADP, the CCES’s file outcome summary can be found at www.cces.ca/sanctionreg.

About the CCES

The CCES is an independent, national, not-for-profit organization with a responsibility to administer the CADP. Under the CADP rules, the CCES announces publicly every anti-doping rule violation. We recognize that true sport can make a great difference for individuals, communities and our country. We are committed to making sport better by working collaboratively to activate a values-based and principle-driven sport system; protecting the integrity of sport from the negative forces of doping and other unethical threats; and advocating for sport that is fair, safe and open to everyone.

-- 30 –

For further information, please contact:

Ben Lungo
Communications Officer
+1 613-521-3340 x3282
blungo@cces.ca